ANKRD22 Enhances Breast Cancer Cell Malignancy by Activating the Wnt β-Catenin Pathway via Modulating NuSAP1 Expression. Biomol Biomed 2021, 21 (3), 294-304. https://doi.org/10.17305/bjbms.2020.4701.